Cover |
|
|
Table of Contents |
|
|
NEWBORN SCREENING HISTORY |
|
The Development of International Cooperation in Newborn Screening and the Efforts ofBob Guthrie and Horst Bickel |
|
H Naruse |
1 |
History of the International Society for Neonatal Screening |
|
B Therrell, Jr, B Wilcken, H Naruse |
3 |
|
|
ESTABLISHMENT, EVALUATION AND IMPROVEMENT OF NEWBORN SCREENING PROGRAMS |
Challenges and Opportunities in Establishing and Maintaining Newborn Screening Systems |
|
BL Therrell |
6 |
Evaluating Outcomes of Newborn Screening Programs |
|
B Wilcke |
13 |
Long Term Follow-up of Patients with Inborn Errors of Metabolism detected by the Newborn Screening Program in
Japan |
|
KAoki |
19 |
Beyond Screening: Challenges in Measuring Outcomes |
|
PD Santos Ocampo, RPR De Guzman, BC Cavan, CD Padilla |
24 |
|
|
NEWBORN SCREENING QUALITY ASSURANCE SYSTEMS |
|
Quality Control System for Mass Screening in Japan |
|
H Naruse, A Tsuji, E Suzuki, N Watanabe, M Maeda, M Fukushi, N Ichihara |
30 |
Development of a Newborn Screening Laboratory Quality Assurance System in Shandong, China |
|
W Wang, X Chen, J Zang, Y He, P Zhang, F Shen |
36 |
Peformance Evaluation for Screening Laboratories of the Asia-Pacific Region |
|
WH Hannon |
39 |
International Developments in Newborn Screening Quality Assurance |
|
D Webster |
43 |
|
|
ETHICAL, LEGAL AND SOCIAL ISSUES IN NEWBORN SCREENING (ELSI) |
Bioethical Considerations in Neonatal Screening: Japanese Experiences |
|
I Matsuda |
46 |
Storage and Use of Residual Dried Blood Spots |
|
D Webster |
49 |
Ethical, Legal and Social Issues in Newborn Screening in the United States |
|
BL Therrell, Jr |
52 |
|
|
SCREENING DATABASES |
|
Information Overload - New Technologies, Can We Store the Data? |
|
V Wiley, K Carpenter, B Bennetts, B Wilcken |
59 |
Data Integration and Warehousing: Coordination Between Newborn Screening and Related Public Health Prograrns |
|
BL Themell, Jr |
63 |
|
|
NEWBORN SCREENING PROGRAMS |
|
Newborn Screening in Australia and New Zealand |
|
D Webste |
69 |
Newborn Screening: Experience of Bangladesh |
|
F Moslem, S Yasmeen, M Hasan, MA Karim, N Nahar, A Ahmed |
71 |
Neonatal Screening in Hong Kong and Macau |
|
STS Lam, ML Cheng |
73 |
Newborn Screening in Indonesia |
|
D Rustama, MR Fadil, ER Harahap, A Primadi |
76 |
Newborn Screening in Japan |
|
K Aoki |
80 |
Newborn Screening in Korea |
|
YJ Han, DH Lee, JW Kim |
81 |
National Neonatal Hypothyroid Screening Program in Mongolia |
|
S Erdenechimeg |
85 |
Newborn Screening in the Philippines |
|
CD Padill |
87 |
Mass Newborn Screening in Singapore |
|
R Joseph |
89 |
Neonatal Screening and Monitoring System in Taiwan |
|
WL Hwu, AC Huang, JS Chen, KJ Hsiao, WY Tsai |
91 |
Neonatal Screening Program in Thailand |
|
W Charoensiriwatana, N Janejai, W Boonwanich, P Krasao, S Chaisomchit, S Waiyasilp |
94 |
|
|
NEONATAL SCREENING ASSAYS |
|
Reuse ofFilter Plates for Elution of Dried Blood Spot Samples in Neonatal Assays |
|
J Hardy, B Link |
101 |
Designing Quality Control for Neonatal Screening Assays |
|
EMR Suolinna, TE Torresani, JO Westgard |
103 |
|
|
TANDEM MASS SPECTROMETRY AND OTHER TECHNOLOGIES: IMPACT ON NEWBORN SCREENING |
MSMS Newborn Screening - Is It Really That Simple? |
|
V Wiley, K Carpenter, U Bayliss, B Wilcken |
107 |
Expanded Newborn Screening by Tandem Mass Spectrometry: The Massachusetts and New England Experience |
|
D Marsden |
111 |
Tandem Mass Spectrometric Analysis for Disorders in Amino, Organic and Fatty Acid Metabolism: Two Year Experience in
South Korea |
|
HR Yoon, KR Lee, H Kim, S Kang, Y Ha, DH Lee |
115 |
Outcomes from Tandem Mass Spectrometiy (MS/MS) Workshops in the United States and the Performance Evaluation of
MS/MS Laboratories |
|
H Hannon, T Lim, 0 Adam, B Therrell |
121 |
|
|
G6PD DEFICIENCY |
|
Glucose-6-Phosphate Dehydrogenase Deficiency: Molecular Heterogeneity in Southeast Asian Countries |
|
M Matsuo, K Nishiyama, T Shirakawa, CD Padilla, LP San, P Suryantoro, NM Yusoff, NTN Dao |
127 |
Quality Assurance Program for Neonatal Screening of Glucose-6-Phosphate Dehydrogenase Deficiency |
|
SH Chiang, KF Wu, TT Liu, SJ Wu, KJ Hsiao |
130 |
G6PD Viangchan and G6PD Mediterranean are the Main Variants in G6PD Deficiency in the Malay Population ofMalaysia |
|
NM Yusoff, T Shirakawa, K Nishiyama, CK Ee, MN Isa, M Matsuo |
135 |
Glucose-6-Phosphate-Dehydrogenase (G6PD) Deficiency in Yogyakarta and its surrounding areas |
|
P Suryantoro |
138 |
Using the Fluorescence Spot Test for Neonatal Screening of G6PD Deficiency |
|
J Jiang, X Ma, C Song, B Lin, W Cao, S Wu, KJ Hsiao |
140 |
Automated Determination of Glucose-6-Phosphate Dehydrogenase (G6PD) on a SPOTCHECK@ Microflow Analyzer |
|
GST Chen, CL Peterson |
143 |
|
|
CONGENITAL HYPOTHYROIDISM |
|
The Investigation of Factors Influencing the Measurement of Thyroid Stimulating Hormone in Dried Blood Spots on Filter
Paper |
|
X Chen, G Wu, Z Song, H Zhou, C Zhou, C Yang, W Wang |
147 |
Detection Through Screening of Maternal Thyrotoxicosis Induced Central Hjpothyroidism In Newborns |
|
R Joseph, YS Lee, SCY Ng, KY Loke |
150 |
The Utility of FT4 Serum in Newborns at Risk For Congenital Hrpothyroidism (CH) |
|
RA Cordova, G Vignola |
152 |
Initial Versus Confirmatory Thyroid Stimulating Hormone (TSH) Levels: Is there a correlation? |
|
SC Estrada, KIT dela Cruz, C Padilla |
154 |
Urinaiy Iodide Levels In Term Newborns And Their Mothers - A Pilot Study |
|
S Chan-Cua, M Ng, I Dayao, C Cuayo-Juico, F King, KK Tan |
158 |
Screening for Congenital Hypothyroidism -A New Era in Bangladesh |
|
M Hasan, N Nahar, A Ahmed, F Moslenl |
162 |
Newborn Screening for Congenital Hypothyroidism in Early Discharged Infants |
|
CF Domingo, CD Padilla |
165 |
|
|
CONGENITAL ADRENAL HYPERPLASIA |
|
CongenitalAdrenal Hyperplasia: Should Nationwide Screening Be Implemented in Thailand? |
|
N Janejai, P Krasao, J Phansang, R Pankamjanato, W Charoensiriwatana |
170 |
Monitoring Congenital Adrenal Hyperplasia Using Blood Spot 17-Hydroxyprogesterone Assay |
|
CM Santos, LR Abad, SC Chua, CF Domingo |
174 |
|
|
DISORDERS IN PHENYLALANINE METABOLISM |
|
Phenylketonzrria Detected by the Neonatal Screening Program in Thailand |
|
S Pangkanon, V Ratrisawadi, W Charoensiriwatana, W Techasena, K Boonpuan, C Srisomsap, J Svasti |
179 |
Hyperphenylalaninemia in the Philippines |
|
SC Estrada, CD Padilla |
182 |
A Survey fir the Incidence of Pkenylketonuria it1 Guangdong, China |
|
J Jiang, X Ma, X Huang, X Pei, H Liu, Z Tan, L Zhu |
185 |
6-Pyruvoyl Tetrahydropterin Synthase Dejciency: A Case Report |
|
SB Capistrano-Estrada, WL Nyhan |
186 |
|
|
OTHER INBORN ERRORS OF METABOLISM |
|
Clinical Evalttation and Emergency Management of Inborn Errors of Metabolism Presenting in the Newborn |
|
J Christodoulou |
189 |
An Introduction to Nutritional Treatment in Inborn Errors ofMetabolism -Different Disorders, Dzfferent Approaches |
|
B Wilcken |
198 |
Challenges of Managing Patients With Inherited Metabolic Disorders in a Developing Country |
|
PB Acosta, R Sabo |
202 |
Practical Aspects of Managing Low Protein Diets |
|
S Thompson |
208 |
Dietary Management of Galactosemia |
|
SM Thompson, FE Arrowsmith, JR Allen |
212 |
Cost-Benejt Analysis of Newborn Screening for Galactosemia in the Philippines |
|
CD Padilla, LF Dans, SC Estrada, MR Tamondong Jr, JJO Laceste, RMS Bemal |
215 |
|
|
INFECTIOUS DISEASES |
|
A Study to Implement Early Diagnosis ofHIVInfection in Infants Born to Infected Mothers |
|
B Sriwanthana, N Wetprasit, S Chareonsook, N Janejai, W Charoensiriwatana |
221 |
|
|
NEWBORN HEARING SCREENING |
|
Universal Neonatal Hearing Screening: Applications for a Developing Country in the Asia-PaciJic Region |
|
CG Navarro-Locsin |
227 |
Mass Newborn Screening for Hearing Impairment |
|
R Joseph, HKK Tan, KT Low, PG Ng, J Tunnel, S Mathew |
229 |
Newborn Hearing Screening Using the Evoked Otoacoustic Emission: The Philippine General Hospital Experience |
|
MRTR Quintos, PFD Isleta, CC Chiong, GT Abes |
231 |
|
|
HUMAN GENOME PROJECT |
|
The Human Genome Project: Opportunities, Challenges and Consequences for Population Screening |
|
J Christodoulou |
234 |
|
|
BIRTH DEFECTS |
|
Birth Defects Ascertainment in the Philippines |
|
CD Padilla, EM Cutiongco, JM Sia |
239 |
Prenatal Genetic Screening for Down Syndrome and Open Neural Tube Defects Using Maternal Serum Markers in Thai
Pregnant Women |
|
P Wasant and S Liarnrnongkolkul |
244 |
|
|